Cracking the Code: Sequencing the Hodgkin Lymphoma Genome to Uncover New Precision Therapies

Hodgkin Lymphoma is the most common cancer type in adolescents and young adults. But until recently, very little was known about the biology of the disease. Enter, Dr. Lisa Roth, Director of Pediatric Oncology at NewYork Presbyterian and Weill Cornell Medicine, and her team of researchers. Their tireless work to pin down the difficult biology of Hodgkin Lymphoma has led them to became the first scientists to map the entire Hodgkin Lymphoma genome, uncovering new pathways to treat this historically understudied cancer-type.